137 related articles for article (PubMed ID: 22223869)
1. Current concepts in the evaluation and treatment of patients with diffuse malignant peritoneal mesothelioma.
Turner K; Varghese S; Alexander HR
J Natl Compr Canc Netw; 2012 Jan; 10(1):49-57. PubMed ID: 22223869
[TBL] [Abstract][Full Text] [Related]
2. Current Management and Future Opportunities for Peritoneal Metastases: Peritoneal Mesothelioma.
Alexander HR; Li CY; Kennedy TJ
Ann Surg Oncol; 2018 Aug; 25(8):2159-2164. PubMed ID: 29423664
[TBL] [Abstract][Full Text] [Related]
3. [Diffuse malignant peritoneal mesothelioma (DMPM) - a rare diagnosis].
Habbel VSA; Mahler EA; Feyerabend B; Oldhafer KJ; Lipp MJ
Z Gastroenterol; 2020 Feb; 58(2):146-151. PubMed ID: 32050285
[TBL] [Abstract][Full Text] [Related]
4. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M
Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal Metastases from Malignant Mesothelioma.
Li CY; Alexander HR
Surg Oncol Clin N Am; 2018 Jul; 27(3):539-549. PubMed ID: 29935688
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study.
Baratti D; Kusamura S; Cabras AD; Deraco M
Ann Surg Oncol; 2012 May; 19(5):1416-24. PubMed ID: 22302266
[TBL] [Abstract][Full Text] [Related]
7. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
[TBL] [Abstract][Full Text] [Related]
8. Diffuse malignant peritoneal mesothelioma--an update on treatment.
Mirarabshahii P; Pillai K; Chua TC; Pourgholami MH; Morris DL
Cancer Treat Rev; 2012 Oct; 38(6):605-12. PubMed ID: 22104079
[TBL] [Abstract][Full Text] [Related]
9. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
[TBL] [Abstract][Full Text] [Related]
10. Mesothelin and osteopontin as circulating markers of diffuse malignant peritoneal mesothelioma: A preliminary study.
Bruno F; Baratti D; Martinetti A; Morelli D; Sottotetti E; Bonini C; Guaglio M; Kusamura S; Deraco M
Eur J Surg Oncol; 2018 Jun; 44(6):792-798. PubMed ID: 29503128
[TBL] [Abstract][Full Text] [Related]
11. The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Deraco M; Baratti D; Hutanu I; Bertuli R; Kusamura S
Ann Surg Oncol; 2013 Apr; 20(4):1093-100. PubMed ID: 23456386
[TBL] [Abstract][Full Text] [Related]
12. Complete pathological response to neoadjuvant pemetrexed/cisplatin in combination with regional hyperthermia in a patient with sarcomatoid peritoneal mesothelioma.
Kruger S; Angele MK; Reu S; Sotlar K; Graser A; Haas M; Albertsmeier M; Stemmler HJ; Heinemann V; Lindner LH; Boeck S
Anticancer Drugs; 2014 Aug; 25(7):854-6. PubMed ID: 24637577
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal mesothelioma.
Hesdorffer ME; Chabot J; DeRosa C; Taub R
Curr Treat Options Oncol; 2008 Jun; 9(2-3):180-90. PubMed ID: 18841478
[TBL] [Abstract][Full Text] [Related]
14. Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma.
Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Intengen ME
J Surg Oncol; 1999 Jan; 70(1):6-12. PubMed ID: 9989414
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal mesothelioma.
Taub RN; Keohan ML; Chabot JC; Fountain KS; Plitsas M
Curr Treat Options Oncol; 2000 Oct; 1(4):303-12. PubMed ID: 12057156
[TBL] [Abstract][Full Text] [Related]
16. [Malignant peritoneal mesothelioma tumours. Evolution, treatment, prognosis].
Scripcariu V; Dajbog E; Radu I; Ferariu D; Pricop A; Grigoraş M; Dragomir C
Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):673-7. PubMed ID: 18293699
[TBL] [Abstract][Full Text] [Related]
17. Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research.
Baratti D; Kusamura S; Deraco M
J Surg Oncol; 2011 Jun; 103(8):822-31. PubMed ID: 21283990
[TBL] [Abstract][Full Text] [Related]
18. Advances in the management of peritoneal mesothelioma.
Raza A; Huang WC; Takabe K
World J Gastroenterol; 2014 Sep; 20(33):11700-12. PubMed ID: 25206274
[TBL] [Abstract][Full Text] [Related]
19. ['Malignant peritoneal mesothelioma': a condition difficult to diagnose].
van der Valk FM; van Leeuwen J
Ned Tijdschr Geneeskd; 2012; 156(15):A4269. PubMed ID: 22495008
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.
Yan TD; Deraco M; Baratti D; Kusamura S; Elias D; Glehen O; Gilly FN; Levine EA; Shen P; Mohamed F; Moran BJ; Morris DL; Chua TC; Piso P; Sugarbaker PH
J Clin Oncol; 2009 Dec; 27(36):6237-42. PubMed ID: 19917862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
